Nvidia's Kimberly Powell uses AI to speed up drug discovery

Nvidia's Kimberly Powell is leading efforts to use AI to accelerate drug discovery, aiming to overcome the lengthy, expensive, and often unsuccessful traditional process. Powell highlights the complexity of diseases like cancer, which involve multiple biological targets. Nvidia is adapting its AI hardware and software to handle the vast and specialized datasets required for biological research, moving beyond typical language models. Powell manages Nvidia's healthcare partnerships, working with major companies and startups to translate research challenges into computational solutions, as part of Fast Company's AI 20 for 2025.